|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS11164 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-RAD51C |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human RAD51C C-terminus |
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-RAD51C
中文名稱 和易感基因RAD51C抗體說明書
別 名 tudor domain containing 1; Tdrd1; MTR-1; FLJ21082; CT41.1; TDRD1_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 132kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human RAD51C C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
和易感基因RAD51C抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. The RAD51B-RAD51C dimer exhibits single-stranded DNA-dependent ATPase activity. The BCDX2 complex binds single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. Participates in branch migration and Holliday junction resolution and thus is important for processing HR intermediates late in the DNA repair process. Also has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis.
Function : Plays a central role during spermatogenesis by participating in the repression transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the localization of Piwi proteins to the meiotic nuage. Involved in the piRNA metabolic process by ensuring the entry of correct transcripts into the normal piRNA pool and limiting the entry of cellular transcripts into the piRNA pathway. May act by allowing the recruitment of piRNA biogenesis or loading factors that ensure the correct entry of transcripts and piRNAs into Piwi proteins
Subunit : Found in a mRNP complex, at least composed of TDRD1, TDRD6, TDRD7 and DDX4. Interacts with MAEL. Interacts with PIWIL1, PIWIL2 and PIWIL4 (when methylated on arginine residues)
Subcellular Location : Cytoplasm. Note=Component of the meiotic nuage, also named P granule, a germ-cell-specific organelle required to repress transposon during meiosis. Also present in chromatoid body.
Tissue Specificity : Expressed in a variety of tissues, with highest expression in testis, heart muscle, spleen and prostate.
Similarity : Belongs to the TDRD1 family.
Contains 1 MYND-type zinc finger.
Contains 4 Tudor domains.
IL-12R Beta2/IL12RB2 peptide 白細(xì)胞介素-12受體β2抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-Acinus Acinus抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-CDKN1B/P27kip1 (Ser178) 磷酸化P27抗體/周期素依賴激酶抑制劑抗體 規(guī)格 0.1ml
狗IgG 干粉 10mg/50mg 國(guó)產(chǎn)
WDR23 英文名稱： WDR23蛋白抗體 0.2ml
DLP1 英文名稱： 動(dòng)力相關(guān)蛋白1抗體 0.1ml
Anti-Acinus Acinus抗體Multi-class antibodies規(guī)格： 0.2ml
Anti-PACAP/VIP receptor-I /FITC 熒光素標(biāo)記腺苷酸環(huán)化酶激活肽受體-I/活性腸肽-I抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rabbit Anti-pig IgG/Biotin 生物素化兔抗豬IgGMulti-class antibodies規(guī)格： 0.3ml
脫羧酶蛋白體36抗體 Anti-CXorf36 0.2ml
Rabbit anti-MG IgG/PE-CY5 PE-CY5標(biāo)記的兔抗長(zhǎng)爪沙鼠IgG 0.1ml
FXYD7 英文名稱： FXYD離子轉(zhuǎn)運(yùn)調(diào)節(jié)因子7抗體 0.2ml
Rhesus antibody Rh phospho-VEGF receptor 2(Tyr1214) 磷酸化內(nèi)皮生長(zhǎng)因子受體2抗體 規(guī)格 0.1ml
Rabbit Anti-pig IgG/Biotin 生物素化兔抗豬IgGMulti-class antibodies規(guī)格： 0.3ml
SAMD14 英文名稱： SAMD14抗體 0.2ml
ENPP1 英文名稱： 核苷酸內(nèi)焦磷酸酶/磷酸二酯酶1抗體 0.2ml
細(xì)胞表面趨化因子受體2A抗體 Anti-CCR-2A 0.1ml
Anti-USP1/FITC 熒光素標(biāo)記泛素特異性蛋白酶1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Phospho-HER3 (Tyr1222) 磷酸化HER3受體抗體 規(guī)格 0.1ml
CD2AP (CD2-associated protein) 白細(xì)胞分化抗原CD2APMulti-class antibodies規(guī)格： 0.5mg
MA, 小鼠星形膠質(zhì)細(xì)胞
Eca-109 人細(xì)胞
EREG Others Human 人 Epiregulin / EREG 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0393NCI-H209(人小細(xì)胞細(xì)胞)5×106cells/瓶×2
人絨毛間葉成纖維細(xì)胞總RNAHVMF NA
人永生化淋巴細(xì)胞;CNLMG-B5538LC 人肝動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
CL-0180P388D1(小鼠淋巴樣瘤細(xì)胞)5×106cells/瓶×2
CD58 Others Human 人 LFA-3 / CD58 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人間充質(zhì)干細(xì)胞-脂肪裂解物HMSC-ad L
ER-30細(xì)胞，人癌細(xì)胞 大鼠腺癌細(xì)胞系,MADB106細(xì)胞 淋巴成纖維細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
B16-F1(小鼠細(xì)胞) 5×106cells/瓶×2
NHEM.f M2 Pellet 正常人表皮黑素細(xì)胞團(tuán)塊(少年者)，培養(yǎng)在M2培養(yǎng)液中 > 1 mio.cells 人氣管上皮細(xì)胞裂解物HTEpiCL
和易感基因RAD51C抗體說明書 MA, 小鼠星形膠質(zhì)細(xì)胞
Eca-109 人細(xì)胞
EREG Others Human 人 Epiregulin / EREG 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0393NCI-H209(人小細(xì)胞細(xì)胞)5×106cells/瓶×2
人絨毛間葉成纖維細(xì)胞總RNAHVMF NA
人永生化淋巴細(xì)胞;CNLMG-B5538LC 人肝動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 和易感基因RAD51C抗體說明書 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）和易感基因RAD51C抗體說明書 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
